cbdbrands com 1 561 325 0482 info cbdbrands com
play

CBDbrands.com +1(561) 325-0482 info@CBDbrands.com 1 - PowerPoint PPT Presentation

CBDbrands.com +1(561) 325-0482 info@CBDbrands.com 1 Forward-Looking Statement To the extent any statements contained in this presentation of CBD Brands, Inc. (the Company) contains forward-looking statements as defined in the


  1. CBDbrands.com • +1(561) 325-0482 •info@CBDbrands.com 1

  2. Forward-Looking Statement To the extent any statements contained in this presentation of CBD Brands, Inc. (the “Company”) contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 and the information that are based upon beliefs of, and information currently available to, the company’s management as well as estimates and assumptions made by the company’s management. These statements can be identified by the fact that they do not relate strictly to historic or current facts. When used in this presentation the words “estimate,” “expect,” intend,” believe,” plan,” “anticipate,” “projected” and other words or the negative of these terms and similar expressions as they relate to the company or the company’s management identify forward-looking statements. Such statements reflect the current view of the company with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to the company’s industry, its operations and results of operations and any businesses that may be acquired by the company. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned. Although the company believes that the expectations reflected in the forward-looking statements are reasonable, the company cannot guarantee future results, performance or achievements. Except as required by applicable law, including the security laws of the United States, the company does not intend to update any of the forward-looking statements to conform these statements to actual results. 2

  3. The Market’s Problem Is Our Opportunity The CBD market is difficult to understand. Patients lack reliable resources to turn to for help in understanding the benefits of CBD, choosing the right formulations and products for their family’s needs, and knowing who to trust for their purchase. Reliability Seed-to-Need Drug Development Trustable resource for news, Tracking the source and only using Effective medical advancements the highest-grade CBD will increase information, and unbiased through innovative drug quality and safety for consumers. product reviews. development 3

  4. The endocannabinoid system plays an important role in the immune response of our skin, including: regulation of cell growth and wound healing, skin homeostasis, and release of inflammatory Underlying mediators. Science Both CB1 and CB2 receptors have been found throughout the skin, making topical applications perfect for treating a rangeof conditions, including: Cannabinoid receptors are found throughout the skin Joint Pain Eczema Arthritis Pain Itchy Rashes Muscle Pain Neck and Back Pain Contact Dermatitis Inflammation Psoriasis Acne 4

  5. CBD Comes In Many Forms Full-Spectrum CBD: Made with the entire plant and does contain trace amounts of THC. To bypass this, many companies produce what is known as CBD isolate: a pure crystalline powder that contains 99% pure CBD. CBD Isolate: All the plant matter that is contained in the hemp plant is removed through a purification process that follows the extraction process. What remains is a final product that only contains CBD without any trace amounts of THC. Broad-Spectrum CBD: This is simply a CBD product with all the benefits of full spectrum products (terpenes, minor cannabinoids, and other natural parts of the cannabis plant) but without the THC. 5

  6. Business Divisions Brands/Products Drug Development CDB Clinics We are actively developing an We plan to run nutraceutical clinical We plan to open specialty CBD retail innovative line of high-quality CBD- trials towards proof of concept and stores throughout the state of Florida infused suncare, skincare, cosmetics, FDA approval. begninning in 2019. We intend to nutraceuticals, and wellness products. expand nationwide through acquisitions and expansion. 6

  7. Our First Brands CBD Brands is a functional wellness and natural health products company. With a tireless devotion to quality, sourcing, and customer care, our goal is to harness and research the scientifically-backed health benefits of CBD such as pain relief and muscle relaxation to help the population live a more fulfilling life through a variety of forthcoming products. 7

  8. We have developed a CBD-infused sunscreen with broad-spectrum SPF protection under the CaniSun™ brand name. We recently launched a suncare line of SPF 30, SPF 55 and SPF 50 face lotion. We have completed lab testing for CBD solubility – infusing clear, colorless, odorless, and 99.5% pure CBD isolate with three different FDA approved suncare actives (homosalate, octisalate and octocrylene). 8

  9. Moisturizing Body Lotion Spray Sunscreen Sunscreen Lipbalm Product Line 9

  10. Quality Lab Process Addition of Batch Lab Testing Tube Fill Ingredients Mixing for Quality 10

  11. Currently in development, we are working to perfect a line of CBD-infused skin care lotion. Providing daily sun protection with broad-spectrum SPF protection and fast-absorbing retinol, our formulation will work quickly to smooth the look of fine lines while the CBD-infused moisture enrichment will not only work to plump the skin but also soothe muscle aches, relieve pain, and reduce unwanted inflammation. 11

  12. We are developing a shelf-stable CBD product to replace traditional sweeteners for you everyday beverages. Using proprietary CBD formulations our products will not alter the taste or texture of your coffee and provide a great alternative source for daily CBD intake. 12

  13. We have in development an innovative dermatological treatment specialized to treat against atopic dermatitis and other dermatological conditions. Infused with our tested pure CBD, our CaniSkin topical cream provides soothing properties along with revolutionary healing results. This product will be sold OTC. Last year, the drug Dupixent, the new and leading treatment for atopic dermatitis of 2018 achieved sales of Silvadene $319 million along with FDA Silver Sulfadiazine Cream approval. 13

  14. • Used to treat atopic dermatitis • Topical cream application • Injected subcutaneously • Works through endocannabinoid system and Cox-2 inhibition to treat atopic dermatitis • Patients can experience returned dermatitis post treatment • CB2 receptors in human skin are expressed in: • keratinocytes, immune cells, sebaceous glands, • The most common side effects: and sensory neurons • Atopic dermatitis • Asthma: • Promotes: • Chronic rhinosinusitis with nasal • Sebum production polyposis • Modulates pain sensation • Hypersensitivity • Suppresses keratinocyte differentiation and • Swollen blood vessels proliferation • Eye problems • Inhibits inflammatory response in the skin 14

  15. • Topical cream • Topical cream application • FDA approved to temporarily treat cold sores/ fever blisters (herpes labialis) symptoms • Works through endocannabinoid system system and Cox-2 inhibition to treat cold sores and fever • Works by blocking the virus that causes the cold blister symptoms sores from entering the healthy skin cells • CB2 receptors in human skin are expressed in: • Side effects: redness or swelling • keratinocytes, immune cells, sebaceous glands, and sensory neurons • Does not cure herpes, merely prevents further spreading, only temporary relief • Promotes: • Sebum production Market Info • Modulates pain sensation • Suppresses keratinocyte differentiation and • 70% of market proliferation • $200M in sales • Inhibits inflammatory response in the skin 15

  16. Silvadene Silver Sulfadiazine Cream • Prescription topical cream • Topical cream application • Used with other treatments to help prevent and treat wound infections in patients with serious • Works through endocannabinoid system to sooth burns and system and Cox-2 inhibition treat wound infections and serious burns • Works by stopping the growth of bacteria that may infect an open wound. • CB2 receptors in human skin are expressed in: • keratinocytes, immune cells, sebaceous glands, • Side effects: and sensory neurons • Pain, burning and itching • Skin discoloration • Promotes: • Sebum production • Modulates pain sensation • Suppresses keratinocyte differentiation and proliferation • Inhibits inflammatory response in the skin 16

  17. HealthAide Skin cream used as a nutraceutical in over 100 patients for the treatment of dermatitis, eczema, burns, and itch with patients reporting outstanding results Technologies based on the therapeutic properties of Aspartame for the treatment of pain and inflammation Wide variety of uses in both human and animal health for the treatment of pain and inflammation Formulations include topical cream, lip balm, powder and dog treats 17

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend